Trulieve Cannabis (TCNNF) Accumulated Expenses (2021 - 2022)
Trulieve Cannabis (TCNNF) recorded quarterly Accumulated Expenses of $19.5 million in Q4 2022, down 28.25% quarter-over-quarter from $27.2 million in Q1 2022, and up 188.01% on a YoY basis from $6.8 million in Q4 2021.
Trulieve Cannabis (TCNNF) Accumulated Expenses (2021 - 2022) Analysis & Trends
Trulieve Cannabis' Accumulated Expenses history runs 2 years deep, the most recent figure standing at $19.5 million for Q4 2022.
- In Q4 2022, Accumulated Expenses rose 188.01% year-over-year to $19.5 million; the TTM figure through Dec 2022 stood at $19.5 million (up 188.01% YoY), while the FY2022 annual figure was $19.5 million, up 188.01% from the prior year.
- Accumulated Expenses was $19.5 million for Q4 2022 at Trulieve Cannabis, down from $27.2 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $27.2 million in Q1 2022 to a low of $6.8 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 19.55 Mn |
| Mar 31, 2022 | 27.25 Mn |
| Dec 31, 2021 | 6.79 Mn |